Mytos
Mytos builds robots that grow human cells. Our machines take stem cells as input, and grow them into specific cells like neurons or heart cells. Customers use our platform to scale stem-cell derived therapies to more patients sooner. We're also used to produce cells for testing new drugs on during R&D in Drug Discovery. Mytos is backed by leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists. We're hiring now - visit our website to see open positions
Mytos
Mytos builds robots that grow human cells. Our machines take stem cells as input, and grow them into specific cells like neurons or heart cells. Customers use our platform to scale stem-cell derived therapies to more patients sooner. We're also used to produce cells for testing new drugs on during R&D in Drug Discovery. Mytos is backed by leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists. We're hiring now - visit our website to see open positions
TL;DR
What they do: Build automated robots (iDEM) to grow stem-cell derived human cells and operate an automated CDMO for regenerative-medicine production
HQ: London, United Kingdom
Founders: Ali Afshar and Ignacio Willats
Funding: Company states >$24M raised; reports reference a ~$19M Series A
Employee count: 48
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Scaling manufacturing of stem-cell derived therapies and producing consistent, high-throughput human cells for therapeutic and drug-discovery use cases.
Industry
Biotechnology Research
Funding Track Record
$19.0M
Reported by dealroom and company newsroom
Investor Signal
“Includes investors such as Wing Venture Capital, IQ Capital, and Buckley Ventures; additional angels and founders/executives from technology and biotech companies are listed as backers”